Publications (13)

2023

  1. Current Treatments and New, Tentative Therapies for Parkinson’s Disease

    Pharmaceutics, Vol. 15, Núm. 3

  2. Poor Cognitive Agility Conservation in Obese Aging People

    Biomedicines, Vol. 11, Núm. 1

  3. Metabolic Disturbance of High-Saturated Fatty Acid Diet in Cognitive Preservation

    International Journal of Molecular Sciences, Vol. 24, Núm. 9

  4. Current Treatments and New, Tentative Therapies for Parkinson’s Disease

    Pharmaceutics, Vol. 15, Núm. 3, pp. 770

2022

  1. Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives

    Pharmaceutics, Vol. 14, Núm. 6

  2. Prevalence of Depression and Related Factors among Patients with Chronic Disease during the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

    Diagnostics, Vol. 12, Núm. 12

2021

  1. Current understanding of the physiopathology, diagnosis and therapeutic approach to alzheimer’s disease

    Biomedicines, Vol. 9, Núm. 12

  2. Lysophosphatidic Acid and Several Neurotransmitters Converge on Rho-Kinase 2 Signaling to Manage Motoneuron Excitability

    Frontiers in Molecular Neuroscience, Vol. 14

  3. Interfering with lysophosphatidic acid receptor edg2/lpa1 signalling slows down disease progression in SOD1-G93A transgenic mice

    Neuropathology and Applied Neurobiology, Vol. 47, Núm. 7, pp. 1004-1018

2019

  1. Sp1-regulated expression of p11 contributes to motor neuron degeneration by membrane insertion of TASK1

    Nature Communications, Vol. 10, Núm. 1

2015

  1. Membrane-Derived Phospholipids Control Synaptic Neurotransmission and Plasticity

    PLoS Biology, Vol. 13, Núm. 5

  2. Cannabinoid agonists rearrange synaptic vesicles at excitatory synapses and depress motoneuron activity in vivo

    Neuropharmacology, Vol. 92, pp. 69-79

2012

  1. Endogenous rho-kinase signaling maintains synaptic strength by stabilizing the size of the readily releasable pool of synaptic vesicles

    Journal of Neuroscience, Vol. 32, Núm. 1, pp. 68-84